Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 16, Issue 4, 2010, Pages 629-640

  Rosenstock, Julio ^a   Fonseca, Vivian A ^b   Garvey, W Timothy ^b   Goldberg, Ronald B ^b   Handelsman, Yehuda ^b   Abby, Stacey L ^b   Lai, Yu Ling ^b   Jin, Xiaoping ^b   Misir, Soamnauth ^b   Nagendran, Sukumar ^b   Jones, Michael R ^b  

^a DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE; ANTIDIABETIC AGENT; COLESEVELAM; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TIME;

ADOLESCENT; ADULT; AGED; ALLYLAMINE; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; METFORMIN; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 78650205817     PISSN: None     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10130.OR     Document Type: Article

References (0)